FDA Approved: VIOKACE — Supplemental Application (Aimmune Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VIOKACE (pancrelipase) from Aimmune Therapeutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency

Drugs mentioned

• VIOKACE (PANCRELIPASE)

Snippet

SUPPL AP for VIOKACE (PANCRELIPASE)